Anaphylaxis to gadolinium radiocontrast: a case report and review of the literature.
Meagan W. Shepherd, Suman Lata, Sandhya Mani, Annette Fiorillo, Prem Kumar
Abstract
Meagan W. Shepherd, Suman Lata, Sandhya Mani, Annette Fiorillo, Prem Kumar
Abstract
Gadolinium was first introduced in 1988 for use in magnetic resonance imaging. The safety of gadolinium chelates is well established with lower frequency of adverse reactions than non-ionic iodinated contrast media; however, serious adverse reactions can occur. We report a rare case of anaphylaxis after intravenous administration of gadopentetate dimeglumine (Magnevist), used for magnetic resonance imaging.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Gadolinium was first introduced in 1988 for use in magnetic resonance imaging. The safety of gadolinium chelates is well established with lower frequency of adverse reactions than non-ionic iodinated contrast media; however, serious adverse reactions can occur. We report a rare case of anaphylaxis after intravenous administration of gadopentetate dimeglumine (Magnevist), used for magnetic resonance imaging.
Key concepts: Gadolinium, Medicine, Anaphylaxis, Iodinated contrast, Magnetic resonance imaging, Adverse effect, Gadolinium DTPA, Radiology